Hematology & Oncology Doctors in West Long Branch, NJ Accepting Medicare

3 Hematology & Oncology doctors found. Showing 1 - 3

Patrick Lee, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 Hwy 36, West Long Branch, NJ 07764 Phone: 732-222-1711    Fax: 732-222-1461

David J Sharon, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 100 State Route 36, Suite 1b, West Long Branch, NJ 07764 Phone: 732-222-1711    Fax: 732-222-2060

Debra M Ray, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 100 State Route 36, West Long Branch, NJ 07764 Phone: 732-222-1711    Fax: 732-222-2060

News Archive

IQWiG investigates benefit of biomarker tests to support decision on adjuvant chemotherapy

The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated the benefit of biomarker tests to support the decision for or against adjuvant systemic chemotherapy in certain breast cancer patients, that is, women with primary hormone receptor-positive, HER2-negative breast cancer and up to 3 affected lymph nodes.

Researchers develop novel strategy in fight against cancer

A team of researchers led by Associate Professor Caroline Lee from the Yong Loo Lin School of Medicine at the National University of Singapore, in collaboration with Associate Professor Song Jianxing of the Department of Biological Sciences at the NUS Faculty of Science, has developed a novel strategy in the fight against cancer.

2009 International Society meeting to focus on hip arthroscopy

Recent advances in diagnostic imaging techniques and hip arthroscopy procedures are giving physicians and surgeons better tools with which to treat hip pain. The 2009 International Society for Hip Arthroscopy meeting, hosted by Hospital for Special Surgery in New York, brings together leading surgeons from all over the world to take an in-depth look at hip arthroscopy and its potential benefits.

Researchers identify antibodies that hold promise as Ebola treatments

The fight to contain the 2013-16 Ebola outbreak in West Africa was hampered by the lack of an effective treatment or vaccine. Researchers funded in part by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have studied the blood of an Ebola survivor, searching for human antibodies that might effectively treat not only people infected with Ebola virus, but those infected with related viruses as well.

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.

Read more Medical News

› Verified 1 days ago